Abstract
Extracorporeal life support (ECLS) is a set of therapies that focus on oxygenation, carbon dioxide removal, and circulatory support to provide adequate oxygen delivery to the tissues for the time needed to restore damaged cardiac or pulmonary function, identify therapeutic options, or plan a transplantation or long-term mechanical support implantation.
ELCS is, at present, a highly specialized therapy, and the possibility to deliver it in the emergency department depends largely on the existence of an ECLS program in the center or from a retrieval team arriving from a hub center.
Different configurations allow for different indications. Namely, ECLS with veno-arterial cannulation provides circulatory and respiratory support, while in its veno-venous configuration, it delivers uniquely respiratory assistance.
The main indication for the use of ECLS in the emergency department is represented by cardiogenic shock, a life-threatening clinical syndrome characterized by cardiac dysfunction resulting in end-organ hypoperfusion, tissue hypoxia, and increased lactate levels. ECLS can also be applied in patients suffering from cardiac arrest in whom conventional cardiopulmonary resuscitation is unsuccessful in achieving a sustained return of spontaneous circulation. Finally, indications for ECLS in respiratory failure in the emergency department are limited, since most patients are generally managed with mechanical ventilation upon presentation, while the indication for ECLS is commonly a second line.
So far, when an ECLS is initiated in an emergency department, a highly specialized multidisciplinary team is required. However, future directions imply the development of portable, automated, and biocompatible devices to be easily used in a larger number of emergency departments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ELSO ELSO. ELSO International Summary 2021; 2021.
Barbaro RP, MacLaren G, Boonstra PS, Combes A, Agerstrand C, Annich G, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international extracorporeal life support organization registry. Lancet. 2021;398(10307):1230–8.
Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–63.
Badulak J, Antonini MV, Stead CM, Shekerdemian L, Raman L, Paden ML, et al. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J. 2021;67(5):485–95.
Lamhaut L, Hutin A, Deutsch J, Raphalen JH, Jouffroy R, Orsini JP, et al. Extracorporeal cardiopulmonary resuscitation (ECPR) in the prehospital setting: an illustrative case of ECPR performed in the louvre museum. Prehosp Emerg Care. 2017;21(3):386–9.
Conrad SA, Broman LM, Taccone FS, Lorusso R, Malfertheiner MV, Pappalardo F, et al. The extracorporeal life support organization Maastricht treaty for nomenclature in extracorporeal life support. A position paper of the extracorporeal life support organization. Am J Respir Crit Care Med. 2018;198(4):447–51.
Broman LM, Taccone FS, Lorusso R, Malfertheiner MV, Pappalardo F, Di Nardo M, et al. The ELSO Maastricht treaty for ECLS nomenclature: abbreviations for cannulation configuration in extracorporeal life support—a position paper of the extracorporeal life support organization. Crit Care. 2019;23(1):36.
Lorusso R, Shekar K, MacLaren G, Schmidt M, Pellegrino V, Meyns B, et al. ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J. 2021;67(8):827–44.
Lorusso R, Whitman G, Milojevic M, Raffa G, McMullan DM, Boeken U, et al. 2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients. J Thorac Cardiovasc Surg. 2021;161(4):1287–331.
Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965–75.
Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock—a position statement from the heart failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(8):1315–41.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019;94(1):29–37.
Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;
Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV. Cardiogenic shock after acute myocardial infarction: a review. JAMA. 2021;326(18):1840–50.
Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297(17):1892–900.
Samsky M, Krucoff M, Althouse AD, Abraham WT, Adamson P, Aguel F, et al. Clinical and regulatory landscape for cardiogenic shock: a report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. Am Heart J. 2020;219:1–8.
Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019;40(32):2671–83.
Khalid L, Dhakam SH. A review of cardiogenic shock in acute myocardial infarction. Curr Cardiol Rev. 2008;4(1):34–40.
Saeed O, Tatooles AJ, Farooq M, Schwartz G, Pham DT, Mustafa AK, et al. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: a retrospective multicenter study. J Thorac Cardiovasc Surg. 2021;
De Piero ME, Lo Coco V, Taccone FS, Belliato M, Broman LM, Malfertheiner MV, et al. Has Venoarterial ECMO Been Underutilized in COVID-19 Patients? Innovations (Phila). 2020;15(4):317–21.
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke Statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–596.
Grasner JT, Herlitz J, Tjelmeland IBM, Wnent J, Masterson S, Lilja G, et al. European resuscitation council guidelines 2021: epidemiology of cardiac arrest in Europe. Resuscitation. 2021;161:61–79.
Schluep M, Gravesteijn BY, Stolker RJ, Endeman H, Hoeks SE. One-year survival after in-hospital cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2018;132:90–100.
Thompson LE, Chan PS, Tang F, Nallamothu BK, Girotra S, Perman SM, et al. Long-term survival trends of Medicare patients after in-hospital cardiac arrest: insights from get with the guidelines-resuscitation(®). Resuscitation. 2018;123:58–64.
Soar J, Bottiger BW, Carli P, Couper K, Deakin CD, Djarv T, et al. European resuscitation council guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115–51.
Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO J. 2021;67(6):601–10.
Lorusso R, Combes A, Coco VL, De Piero ME, Belohlavek J. ECMO for COVID-19 patients in Europe and Israel. Intensive Care Med. 2021;47(3):344–8.
Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071–8.
Odish MF, Yi C, Chicotka S, Genovese B, Golts E, Madani M, et al. Implementation and outcomes of a Mobile extracorporeal membrane oxygenation program in the United States during the coronavirus disease 2019 pandemic. J Cardiothorac Vasc Anesth. 2021;35(10):2869–74.
Willers A, Arens J, Mariani S, Pels H, Maessen JG, Hackeng TM, et al. New trends, advantages and disadvantages in anticoagulation and coating methods used in extracorporeal life support devices. Membranes (Basel). 2021;11(8)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
None
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sangalli, F., Mariani, S., Fumagalli, R. (2023). Extracorporeal Life Support (ECLS) for Critically Ill Patients in the Emergency Department. In: Aseni, P., Grande, A.M., Leppäniemi, A., Chiara, O. (eds) The High-risk Surgical Patient. Springer, Cham. https://doi.org/10.1007/978-3-031-17273-1_31
Download citation
DOI: https://doi.org/10.1007/978-3-031-17273-1_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-17272-4
Online ISBN: 978-3-031-17273-1
eBook Packages: MedicineMedicine (R0)